Here, concomitant CD44 expression and HA pericellular deposition on ovarian cancer cells might result in pro-tumorigenic signaling activation, thereby explaining the more malignant tumor phenotype and the poorer prognosis of those patients displaying an ovarian cancer-cell-associated HA-deposition pattern. Here, CD44 is linked to ovarian carcinoma.